In addition, as shown in Fig. 4E,F, the expression rate of α-SMA in the benign lesions was significantly lower than that in malignancy (P < 0.01), while the expression grade of CD34 in benign breast tissues was dramatically higher than in breast cancers (P < 0.01). This evidence concerns the gene ACTA1 and breast cancer.